Arcutis Biotherapeutics Inc (ARQT)
9.36
+0.20
(+2.18%)
USD |
NASDAQ |
Sep 27, 16:00
9.365
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Gross Profit (Quarterly): 27.39M for June 30, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 27.39M |
March 31, 2024 | 46.31M |
December 31, 2023 | 11.28M |
September 30, 2023 | 36.93M |
June 30, 2023 | 4.414M |
March 31, 2023 | 1.998M |
Date | Value |
---|---|
December 31, 2022 | 2.476M |
September 30, 2022 | 0.456M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2021
46.31M
Maximum
Mar 2024
10.94M
Average
2.237M
Median
Gross Profit (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 14.00M |
Heron Therapeutics Inc | 25.51M |
Rocket Pharmaceuticals Inc | -- |
Zevra Therapeutics Inc | 0.876M |
Axsome Therapeutics Inc | 79.11M |